SUBSCRIBE
SUBSCRIBE
News   Business

Bridge Pharmaceuticals, Inc. Takes On China With $22M Series B

May 30, 2006 | 
1 min read
5/30/2006 - Bridge Pharmaceuticals Inc., a contract drug researcher looking to perform studies in greater China for biotech and pharmaceutical companies, has raised $22 million in Series B financing.
Startups
MORE ON THIS TOPIC
3d illustration of a black dragon flying on an extraterrestrial world with mountains beneath.
Neuropsychiatric disorders
Draig Takes Flight With $140M Series A To Advance Neuropsych Drugs
June 18, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Lycia Cuts Staff More Than One Year After $106M Series C
June 18, 2025
 · 
143 min read
 · 
BioSpace Editorial Staff
Podcast
Another Gene Therapy Death; Biopharma M&A Picks Up; a Vaccine Board of Vaccine Skeptics
June 18, 2025
 · 
1 min read
 · 
Heather McKenzie
3D. The Red rocket that soars high and different than other rockets. Startup business successful concept.
Mergers & acquisitions
Lilly Validates Gene Editing Space With $1.3B Verve Buy, But Analysts Are Skeptical
June 17, 2025
 · 
3 min read
 · 
Annalee Armstrong